Trial Profile
Phase 2 study of weekly oxaliplatin and capecitabine in combination with preoperative radiotherapy in patients with MRI defined locally advanced rectal cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Dec 2009
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary) ; Capecitabine
- Indications Rectal cancer
- Focus Therapeutic Use
- Acronyms CORE
- 30 Oct 2005 Results presented at the 13th European Cancer Conference (ECCO) 2005.
- 16 Oct 2005 New trial record.